Journal of Child Neurology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Connors, S. L.
Right arrow Articles by Zimmerman, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Connors, S. L.
Right arrow Articles by Zimmerman, A. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Child Neurology, Vol. 20, No. 11, 876-884 (2005)
DOI: 10.1177/08830738050200110401

ß 2-Adrenergic Receptor Activation and Genetic Polymorphisms in Autism: Data from Dizygotic Twins

Susan L. Connors, MD

Department of Neurology and Developmental Medicine Kennedy Krieger Institute, Baltimore, MD

Dorothy E. Crowell

Department of Neurology and Developmental Medicine Kennedy Krieger Institute, Baltimore, MD

Charles G. Eberhart, MD, PhD

Department of Pathology Johns Hopkins University School of Medicine, Baltimore, MD

Joshua Copeland

Department of Pathology Johns Hopkins University School of Medicine, Baltimore, MD

Craig J. Newschaffer, PhD

Department of Epidemiology Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD

Sarah J. Spence, MD, PhD

Departments of Psychiatry and Pediatrics David Geffen School of Medicine at UCLA, Los Angeles, CA

Andrew W. Zimmerman, MD

Department of Neurology and Developmental Medicine Kennedy Krieger Institute, Baltimore, MD, zimmerman{at}kennedykrieger.org.

Gestational and genetic factors can contribute to autism during infancy and early childhood through their effects on fetal brain development. Previous twin studies have shown strong genetic components for the development of autism, a disorder that can have multiple causes. We investigated the effects of prenatal overstimulation of the ß2-adrenergic receptor in dizygotic twins who were exposed to terbutaline, a selective ß2-adrenergic receptor agonist used to treat premature labor, as a gestational factor. As a possible genetic mechanism, we studied two ß2-adrenergic receptor polymorphisms in twins from whom DNA was available: glycine substitution at codon 16 (16G) and glutamic acid substitution at codon 27 (27E), which show diminished desensitization in vivo compared with the wild-type receptor. Continuous terbutaline exposure for 2 weeks or longer was associated with increased concordance for autism spectrum disorders in dizygotic twins (relative risk = 2.0), with a further increase in the risk for male twins with no other affected siblings (relative risk = 4.4). A significant association was found between the presence of 16G and 27E polymorphisms in autistic patients compared with population controls (P = .006). Prenatal overstimulation of the ß2-adrenergic receptor by terbutaline or by increased signaling of genetic polymorphisms of the ß2-adrenergic receptor that have diminished desensitization can affect cellular responses and developmental programs in the fetal brain, leading to autism. (J Child Neurol 2005;20:876—884).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. C. Zerrate, M. Pletnikov, S. L. Connors, D. L. Vargas, F. J. Seidler, A. W. Zimmerman, T. A. Slotkin, and C. A. Pardo
Neuroinflammation and Behavioral Abnormalities after Neonatal Terbutaline Treatment in Rats: Implications for Autism
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 16 - 22.
[Abstract] [Full Text] [PDF]